{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:46:23Z","timestamp":1791276383703,"version":"4.1.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPAA"],"DOI":"10.2147\/cpaa.s62512","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T19:35:02Z","timestamp":1399577702000},"page":"87","source":"Crossref","is-referenced-by-count":14,"title":["Incidence and management of adverse events in patients with relapsed and\/or refractory multiple myeloma receiving single-agent carfilzomib"],"prefix":"10.2147","author":[{"given":"Donald","family":"Harvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,5]]},"container-title":["Clinical Pharmacology: Advances and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=19941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:23:04Z","timestamp":1477851784000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/incidence-and-management-of-adverse-events-in-patients-with-relapsed-a-peer-reviewed-article-CPAA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/cpaa.s62512","relation":{},"ISSN":["1179-1438"],"issn-type":[{"value":"1179-1438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}